Amicus Therapeutics continues soaring By: MarketMinute » Stock News August 27, 2014 at 10:30 AM EDT Shares of Amicus Therapeutics Inc. (Nasdaq: FOLD) continued soaring by gaining 64 cents to close at $6.84 after reporting successful late stage trial results last week. Related Stocks: Amicus Therapeutics